Phibro: 3 Key Takeaways for Long-Term Investors
On its first-quarter fiscal year 2027 earnings call, held on Nov. 5, 2026, Phibro (NASDAQ:PAHC) reported net sales of $386.8 million, up 6% year over year despite softness in the poultry market. Long-term investors need to track how the company shifts revenue into higher-margin specialty products while working down excess inventory. Three things management said stand out. Performance Products sales grew 16%, and Mineral Nutrition rose 17% during the quarter. Management is intentionally pivoting these business units toward plant nutrition, dairy, and pet food to build durable, higher-margin customer relationships. U.S. chicken supply grew over 2%, outpacing consumer demand and squeezing producer margins. Farm operators responded by trimming product inventories and pausing purchases of nutritional specialties and vaccines. Continue reading